| Dr James Paul Burke, MD, PHD | |
|
501 Howard Ave, Building F-3, Altoona, PA 16601 | |
| (814) 946-9150 | |
| (814) 946-1397 |
| Full Name | Dr James Paul Burke |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 28 Years |
| Location | 501 Howard Ave, Altoona, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720151855 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | MD066471L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Upmc Altoona | Altoona, PA | Hospital |
| Upmc Bedford Memorial | Everett, PA | Hospital |
| Penn Highlands Huntingdon | Huntingdon, PA | Hospital |
| Nason Medical Center, Llc | Roaring spring, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allegheny Brain And Spine Surgeons Pc | 8123065125 | 2 |
| Vantage Physical Therapy And Rehabilitation Inc | 3072424886 | 168 |
News Archive
Researchers of the "Cell Biology and Physiology-LABRET" group of the University of Malaga (UMA), together with the Networking Biomedical Research Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), have described a new genetic skeletal disorder based on a precision medicine strategy.
Some people will find the new rules make insurance more expensive. That's in part because their health insurance was made cheap by turning away sick people. The new rules also won't allow for as much discrimination based on age or gender. The flip side of that, of course, is that many will suddenly find their health insurance is much cheaper, or they will find that, for the first time, they're not turned away when they try to buy health insurance (Ezra Klein, 6/1).
SIRIUS XM Radio today announced that it will broadcast The Dean's List: A Decade in Medicine, an in-depth special exploring the medical breakthroughs and milestones of the last ten years hosted by Dr. Andrew Brotman, Vice Dean for Clinical Affairs, NYU Langone Medical Center, on Doctor Radio, SIRIUS XM's 24/7 health and medical channel.
This is a generally accepted piece of received wisdom amongst clinicians and care professionals, which MindMetre validated through a series of qualitative interviews that preceded our quantitative study.
Committee for Medicinal Products for Human Use of the European Agency for the Evaluation of Medicinal Products has issued a positive opinion recommending approval of expanded labeling for REMICADE(R) (infliximab), in combination with methotrexate, for treatment of active and progressive psoriatic arthritis (PsA) in patients who have responded inadequately to disease modifying anti- rheumatic drugs (DMARDs).
› Verified 5 days ago
| Entity Name | University Orthopedics Center, Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770500415 PECOS PAC ID: 4284528621 Enrollment ID: O20040209000496 |
News Archive
Researchers of the "Cell Biology and Physiology-LABRET" group of the University of Malaga (UMA), together with the Networking Biomedical Research Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), have described a new genetic skeletal disorder based on a precision medicine strategy.
Some people will find the new rules make insurance more expensive. That's in part because their health insurance was made cheap by turning away sick people. The new rules also won't allow for as much discrimination based on age or gender. The flip side of that, of course, is that many will suddenly find their health insurance is much cheaper, or they will find that, for the first time, they're not turned away when they try to buy health insurance (Ezra Klein, 6/1).
SIRIUS XM Radio today announced that it will broadcast The Dean's List: A Decade in Medicine, an in-depth special exploring the medical breakthroughs and milestones of the last ten years hosted by Dr. Andrew Brotman, Vice Dean for Clinical Affairs, NYU Langone Medical Center, on Doctor Radio, SIRIUS XM's 24/7 health and medical channel.
This is a generally accepted piece of received wisdom amongst clinicians and care professionals, which MindMetre validated through a series of qualitative interviews that preceded our quantitative study.
Committee for Medicinal Products for Human Use of the European Agency for the Evaluation of Medicinal Products has issued a positive opinion recommending approval of expanded labeling for REMICADE(R) (infliximab), in combination with methotrexate, for treatment of active and progressive psoriatic arthritis (PsA) in patients who have responded inadequately to disease modifying anti- rheumatic drugs (DMARDs).
› Verified 5 days ago
| Entity Name | Allegheny Brain And Spine Surgeons Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528131331 PECOS PAC ID: 8123065125 Enrollment ID: O20050412000307 |
News Archive
Researchers of the "Cell Biology and Physiology-LABRET" group of the University of Malaga (UMA), together with the Networking Biomedical Research Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), have described a new genetic skeletal disorder based on a precision medicine strategy.
Some people will find the new rules make insurance more expensive. That's in part because their health insurance was made cheap by turning away sick people. The new rules also won't allow for as much discrimination based on age or gender. The flip side of that, of course, is that many will suddenly find their health insurance is much cheaper, or they will find that, for the first time, they're not turned away when they try to buy health insurance (Ezra Klein, 6/1).
SIRIUS XM Radio today announced that it will broadcast The Dean's List: A Decade in Medicine, an in-depth special exploring the medical breakthroughs and milestones of the last ten years hosted by Dr. Andrew Brotman, Vice Dean for Clinical Affairs, NYU Langone Medical Center, on Doctor Radio, SIRIUS XM's 24/7 health and medical channel.
This is a generally accepted piece of received wisdom amongst clinicians and care professionals, which MindMetre validated through a series of qualitative interviews that preceded our quantitative study.
Committee for Medicinal Products for Human Use of the European Agency for the Evaluation of Medicinal Products has issued a positive opinion recommending approval of expanded labeling for REMICADE(R) (infliximab), in combination with methotrexate, for treatment of active and progressive psoriatic arthritis (PsA) in patients who have responded inadequately to disease modifying anti- rheumatic drugs (DMARDs).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James Paul Burke, MD, PHD 501 Howard Ave Ste E1, Altoona, PA 16601-4817 Ph: (814) 946-9150 | Dr James Paul Burke, MD, PHD 501 Howard Ave, Building F-3, Altoona, PA 16601 Ph: (814) 946-9150 |
News Archive
Researchers of the "Cell Biology and Physiology-LABRET" group of the University of Malaga (UMA), together with the Networking Biomedical Research Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), have described a new genetic skeletal disorder based on a precision medicine strategy.
Some people will find the new rules make insurance more expensive. That's in part because their health insurance was made cheap by turning away sick people. The new rules also won't allow for as much discrimination based on age or gender. The flip side of that, of course, is that many will suddenly find their health insurance is much cheaper, or they will find that, for the first time, they're not turned away when they try to buy health insurance (Ezra Klein, 6/1).
SIRIUS XM Radio today announced that it will broadcast The Dean's List: A Decade in Medicine, an in-depth special exploring the medical breakthroughs and milestones of the last ten years hosted by Dr. Andrew Brotman, Vice Dean for Clinical Affairs, NYU Langone Medical Center, on Doctor Radio, SIRIUS XM's 24/7 health and medical channel.
This is a generally accepted piece of received wisdom amongst clinicians and care professionals, which MindMetre validated through a series of qualitative interviews that preceded our quantitative study.
Committee for Medicinal Products for Human Use of the European Agency for the Evaluation of Medicinal Products has issued a positive opinion recommending approval of expanded labeling for REMICADE(R) (infliximab), in combination with methotrexate, for treatment of active and progressive psoriatic arthritis (PsA) in patients who have responded inadequately to disease modifying anti- rheumatic drugs (DMARDs).
› Verified 5 days ago